Search
Allogene Therapeutics Inc
ALLOAdd to Watchlist
1.845USD
-0.035-1.86%
Market hours （ET）Quotes delayed by 15 min
451.69MMarket Cap
LossP/E TTM
Allogene Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Allogene Therapeutics Inc is 8.08, ranking 128 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.46, which is -68.09% below the recent high of -0.78 and -40.51% above the recent low of -3.45.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.